|
⚲
|
| Keyboard |
| Breum Casper
✚
|
|
|---|---|
| CIK # | 0001630850 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001630850] | |
| 4 | [0001630850] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Breum Casper | |
| Spero Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spero Therapeutics Inc SPRO
Stock Option (right to buy) · derivative
|
2018-06-05 | Grant | 6,073 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2017-11-06 | Conversion | 289,102 | ||
|
Spero Therapeutics Inc SPRO
Common Stock
|
2017-11-06 | Conversion | 408,937 | ||
|
Spero Therapeutics Inc SPRO
Common Stock
|
2017-11-06 | Conversion | 179,450 | ||
|
Spero Therapeutics Inc SPRO
Common Stock
|
2017-11-06 | Buy | 214,285 | $14.00 | 2,999,990 |
|
Spero Therapeutics Inc SPRO
Series C Preferred Stock · derivative
|
2017-11-06 | Conversion | 2,485,272 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Series A Preferred Stock · derivative
|
2017-11-06 | Conversion | 1,153,846 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Series B Preferred Stock · derivative
|
2017-11-06 | Conversion | 681,818 | $0.00 |